Siemens, D Robert <br/><br/>
Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial.  [electronic resource] 

 -  The Journal of urology  01 2018 
 - 147-154 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1527-3792 
<br/><br/><label>Standard No.: </label>10.1016/j.juro.2017.08.080  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Anilides--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Benzamides<br/>Double-Blind Method<br/>Humans<br/>Male<br/>Middle Aged<br/>Nitriles--adverse effects<br/>Phenylthiohydantoin--adverse effects<br/>Progression-Free Survival<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Tosyl Compounds--adverse effects<br/>Treatment Outcome